Tactile Systems Technology’s consensus analyst price target remains steady at $16.83 per share, reflecting unchanged expectations for the company’s future valuation. This stability comes as analysts ...

Roszdravnadzor has added the automated chest compression complex CardioRobot, developed by Rosel Holding, to the state register of medical devices. Rostec has started mass production of the device.

It’s that time of year—the season for wading through sites and sales in search of the perfect gift for every golfer on your nice list. We’ve made your job a bit easier with this roundup of 40 (yes, 40 ...

About Tactile Systems Technology Inc. Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema ...